Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial

Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision label updates from v3.4.1 to v3.4.2; This is a minor maintenance change that does not alter study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T02:18:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision notes show addition of v3.4.1 and removal of v3.4.0, updating the site's notices around operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-09T22:05:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice was added at the top of the page about a lapse in government funding and potential delays in information updates. It also states that the NIH Clinical Center is open and directs users to cc.nih.gov and opm.gov for status updates.
    Difference
    0.4%
    Check dated 2026-02-02T20:55:21.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with revision v3.4.0; older QC labeling and No FEAR Act data wording were removed.
    Difference
    0.2%
    Check dated 2026-01-26T21:04:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3; no visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T15:44:57.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new Locations section was added with District of Columbia, Georgia, Texas, and Washington; the District of Columbia, Georgia, Texas, and Washington location entries were removed; the revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-22T01:31:10.000Z thumbnail image

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.